Intravenous Recombinant Tissue Plasminogen Activator Administered at Three to Six Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis

被引：0
|
作者：
Maiser, Samuel J.
Suri, M. Fareed K.
Georgiadis, Alexandros
Vazquez, Gabriela
Qureshi, Adnan
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [1] Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3-4.5 hours
    Li, Bing-Hu
    Ding, Xin
    Yin, Yan-Wei
    Liu, Yun
    Gao, Chang-Yue
    Zhang, Li-Li
    Li, Jing-Cheng
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1105 - 1114
  • [2] Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis
    Maiser, Samuel J.
    Georgiadis, Alexandros L.
    Suri, M. Fareed K.
    Vazquez, Gabriela
    Lakshminarayan, Kamakshi
    Qureshi, Adnan I.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (01) : 25 - 32
  • [3] Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset
    Sugiura, S.
    Iwaisako, K.
    Toyota, S.
    Takimoto, H.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) : 1061 - 1066
  • [4] Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
    You, Shoujiang
    Saxena, Anubhav
    Wang, Xia
    Tan, WeeYong
    Han, Qiao
    Cao, Yongjun
    Liu, Chun-Feng
    [J]. STROKE AND VASCULAR NEUROLOGY, 2018, 3 (01) : 22 - 27
  • [5] Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke: A Meta-analysis of Randomized Controlled Trials
    Uhrig, Drew
    Kumar, Gyanendra
    Fowler, Susan
    Alexandrov, Andrei
    [J]. STROKE, 2015, 46
  • [6] Vascular Aphasia Outcome after Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Ischemic Stroke
    Jacquin, A.
    Virat-Brassaud, M. -E.
    Rouaud, O.
    Osseby, G. -V.
    Aboa-Eboule, C.
    Hervieu, M.
    Menassa, M.
    Ricolfi, F.
    Giroud, M.
    Bejot, Y.
    [J]. EUROPEAN NEUROLOGY, 2014, 71 (5-6) : 288 - 295
  • [7] Does the administration of sonothrombolysis along with tissue plasminogen activator improve outcomes in acute ischemic stroke? A systematic review and meta-analysis
    Zafar, Marium
    Memon, Roha Saeed
    Mussa, Muhammad
    Merchant, Rameez
    Khurshid, Aiman
    Khosa, Faisal
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 203 - 208
  • [8] Does the administration of sonothrombolysis along with tissue plasminogen activator improve outcomes in acute ischemic stroke? A systematic review and meta-analysis
    Marium Zafar
    Roha Saeed Memon
    Muhammad Mussa
    Rameez Merchant
    Aiman Khurshid
    Faisal Khosa
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 203 - 208
  • [9] Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
    Li, Bing-Hu
    Wang, Jian-Hong
    Wang, Han
    Wang, Duo-Zi
    Yang, Shu
    Guo, Fu-Qiang
    Yu, Neng-Wei
    [J]. FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years
    Mione, Gioia
    Ducrocq, Xavier
    Thilly, Nathalie
    Lacour, Jean-Christophe
    Vespignani, Herve
    Richard, Sebastien
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2016, 16 (07) : 843 - 849
12345